AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Pattern of Dry Eye Disease After Cataract Surgery

Recruitingn/aAges 50 Years - 90 YearsAllLithuanian University of Health Sciences
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with ocular surface inflammation, pain biomarkers after cataract surgery according to ocular surface lubrication with artificial tears during long-term follow-up.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Cataract patients from 50 to 90 years old who underwent uncomplicated phacoemulsification performed by one (and same) experienced surgeon. * Patients with no underlying ocular surface diseases (keratitis, keratoconjunctivitis and others). * Patients who previously did not undergo any ophthalmic surgery. Exclusion Criteria: * Patient expressed his wish to not participate in the study or discontinue it when already enrolled. * Severe dry eye disease diagnosed with OSDI/DEQ-5 and at least one of the following tests: TBUT less than 10 seconds, tear osmolarity higher than 308 mOsm/l or positive corneal staining. * Glaucoma. * Diabetes mellitus. * Systemic connective tissue disease, autoimmune disease. * Neurologic conditions including stroke, Bell's palsy, Parkinson's, trigeminal nerve dysfunction. * Patients who underwent refractive surgery (LASIK or PRK). * Contact lens users. * One or more of the following concomitant medications: psychiatric medicines, antihistamines and/or hormonal replacement. * Patients who are already regularly using topical drops or ointments.
๐Ÿ’Š

What it tests

  • Artificial tears (sodium hyaluronate 0.2%)
๐Ÿ“

Where

1 site
Lithuanian University of Health Sciences
Kaunas, Lithuania
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy